Company Directory / medical devices
PrivateFor profitmedical devicesNew York, United States
Precision Neuroscience
Precision Neuroscience is a neural platform that engages in brain-computer interface technology.
- Founded
- 2021 5 years ago
- Staff
- 11-50 band, as listed
- Followers
- - on LinkedIn
- Funding
- $250M as listed, currency not stated
Set against six million companies
Size
11-50 people: larger than 33% of companies with a size listed
Age
5 years old.
Reach
Website ranked #5,663,299 in the world for traffic, about 1k visits a month.
What it does
MedicalMedical DeviceNeuroscienceProduct Research
Funding, as listed
$250M currency not stated
- Rounds2
- LatestSeries b, Jan 2023
- Investors7, 3 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about Precision Neuroscience, field by field. Contact details are held but never shown.
The company
- Name
- Precision Neuroscience
- Type
- For profit
- Status
- Private
- Founded
- 2021
- Founders
- Benjamin Rapoport, Demetrios Papageorgiou, Mark Hettick, Michael Mager
- Industry
- medical devices
- Categories
- Medical, Medical Device, Neuroscience, Product Research
Where
- City
- New York
- Country
- United States
- Markets
- Greater New York Area, East Coast, Northeastern US
Size and reach
- Staff band
- 11-50
- Web traffic rank
- #5,663,299
- Monthly web visits
- 1,251
Funding, as listed
- Total
- 250,000,000 (currency not stated)
- Rounds
- 2
- Latest round
- Series b
- Latest round date
- Jan 2023
- Investors
- 7
- Lead investors
- 3
- Listing status
- private
About this record
- Sources
- Crunchbase
- Last imported
- Sept 2026
Growth, as the source summarises it
Precision Neuroscience may be growing as it is part of an industry where the brain-computer interface market is expected to reach 7.4 billion by 2033, indicating a robust sector with potential for expansion. Although the news articles provided do not contain specific financial details about Precision Neuroscience, the overall market trend suggests a positive environment for companies in this space. The heightened interest and competition in the field, as evidenced by articles discussing rivals and the race to develop brain implants, imply that Precision Neuroscience operates in a dynamic and potentially lucrative market.
Summaries written by the source dataset, not by us, and not checked.
Companies like it
medical devices in United States.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.